Aclarion (NASDAQ:ACON) Announces Quarterly Earnings Results

Aclarion (NASDAQ:ACON) issued its quarterly earnings data on Wednesday. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.19) by $0.04, Zacks reports. The firm had revenue of $0.01 million during the quarter. Aclarion had a negative return on equity of 2,554.98% and a negative net margin of 10,246.33%.

Aclarion Stock Up 10.5 %

Shares of NASDAQ ACON traded up $0.02 during midday trading on Thursday, hitting $0.23. The stock had a trading volume of 266,645 shares, compared to its average volume of 1,823,694. Aclarion has a fifty-two week low of $0.20 and a fifty-two week high of $9.90. The company’s 50-day simple moving average is $0.29 and its 200 day simple moving average is $0.53.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets started coverage on Aclarion in a report on Monday, July 29th. They issued a “buy” rating and a $1.60 price target for the company.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.